Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Guinea-Bissau
Guinea-Bissau: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology was 2.7% in 2024. ▼ Falling
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Guinea-Bissau, 2015–2024
Source: United Nations Statistics Division, SDG Global Database.
Analysis
Guinea-Bissau recorded 2.7% for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in 2024.
The figure is up 3.8% on the previous year and down 6.9% over ten years.
Over the whole period, prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Guinea-Bissau peaked at 2.9% in 2015 and was at its lowest, 2.6%, in 2022.
That places Guinea-Bissau 7th out of 215 countries with data for 2024, putting it in the top 10%.
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Guinea-Bissau, year by year
| Year | Value | Change |
|---|---|---|
| 2015 | 2.9% | — |
| 2016 | 2.8% | -3.4% |
| 2017 | 2.7% | -3.6% |
| 2018 | 2.7% | +0.0% |
| 2019 | 2.9% | +7.4% |
| 2020 | 2.8% | -3.4% |
| 2021 | 2.9% | +3.6% |
| 2022 | 2.6% | -10.3% |
| 2023 | 2.6% | +0.0% |
| 2024 | 2.7% | +3.8% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 2.8% | 2.7% | 2.9% | 5 |
| 2020s | 2.7% | 2.6% | 2.9% | 5 |
Countries ranked near Guinea-Bissau
More development goals data for Guinea-Bissau
- Red List Index 0.938 (2025)
- Number of refugees per 100,000 population, by country of origin 84.84 (2025)
- Manufacturing value added per capita 74.67 (2025)
- Number of transboundary breeds 14 (2025)
- Number of transboundary breeds (not extinct) 14 (2025)
- Number of transboundary breeds with unknown risk status 14 (2025)
- Number of local breeds with unknown risk status 4 (2025)
- Number of local breeds (not extinct) 4 (2025)
- Number of local breeds kept in the country 4 (2025)
- Infant deaths 2,710 (2024)
Frequently asked questions
- What is prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Guinea-Bissau?
- Prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Guinea-Bissau was 2.7% in 2024, according to United Nations Statistics Division, SDG Global Database.
- What is the highest prevalence of hepatitis b surface antigen (hbsag), 2026 methodology recorded in Guinea-Bissau?
- The highest recorded value was 2.9% in 2015.
- What is the lowest prevalence of hepatitis b surface antigen (hbsag), 2026 methodology recorded in Guinea-Bissau?
- The lowest recorded value was 2.6% in 2022.
- How does Guinea-Bissau rank for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Guinea-Bissau ranks 7th out of 215 countries with data for 2024.
- Is prevalence of hepatitis b surface antigen (hbsag), 2026 methodology rising or falling in Guinea-Bissau?
- Over the last ten years it is down 6.9%. The long-run trend across the full record is falling.
- Where does this Guinea-Bissau data come from?
- The figures come from United Nations Statistics Division, SDG Global Database, published as part of Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under UN SDG Global Database (open, attribution requested).